84 related articles for article (PubMed ID: 65799)
1. Prothrombin determination by means of a chromogenic peptide substrate.
Axelsson G; Korsan-Bengtsen K; Waldenström J
Thromb Haemost; 1976 Dec; 36(3):517-24. PubMed ID: 65799
[TBL] [Abstract][Full Text] [Related]
2. Comparison between British Comparative Thromboplastin (BCT) and a factor II-VII-X determination method (simplastin A) based on fresh plasma samples from dicoumarol-treated patients.
Korsan-Bengtsen K; Johsen M; Pehrsson NG
Thromb Haemost; 1977 Feb; 37(1):98-103. PubMed ID: 65801
[TBL] [Abstract][Full Text] [Related]
3. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
Chmielewska J; Latallo ZS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
[TBL] [Abstract][Full Text] [Related]
4. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
Hjorth B; Kjaersgaard E
Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
[TBL] [Abstract][Full Text] [Related]
5. Study on a new chromogenic substrate for the prothrombin time determination.
Girolami A; Santarossa A; Martinelli S; Sartori MT; Visentin I
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):881-95. PubMed ID: 2453419
[TBL] [Abstract][Full Text] [Related]
6. [Methodological aspects for the determination of the coagulative activity of coagulation factors II, V, VII and X from dog plasma].
Mischke R
Zentralbl Veterinarmed A; 1994 Aug; 41(6):431-42. PubMed ID: 7863734
[TBL] [Abstract][Full Text] [Related]
7. Specific determination of plasmatic thrombin activity.
Stief TW
Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
[TBL] [Abstract][Full Text] [Related]
8. The application of the Reaction Rate Analyser LKB 8600 as an automatic coagulometer.
Andersen I; Thorsen S
Scand J Clin Lab Invest; 1977 Feb; 37(1):7-13. PubMed ID: 616030
[TBL] [Abstract][Full Text] [Related]
9. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
Mischke R; Deniz A; Nolte I
Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
[TBL] [Abstract][Full Text] [Related]
11. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
Svendsen L; Brogli M; Stocker K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
[TBL] [Abstract][Full Text] [Related]
12. The influence of residual factor VII on the sensitivity of brain thromboplastin.
Spurling NW; Savory J
Thromb Haemost; 1978 Jun; 39(3):592-9. PubMed ID: 705687
[TBL] [Abstract][Full Text] [Related]
13. [A chromogenic method for rapid identification of Staphylococcus aureus].
Langlet S; Quentin G; Contant G; Ghnassia JC
Ann Biol Clin (Paris); 1999; 57(2):191-6. PubMed ID: 10210745
[TBL] [Abstract][Full Text] [Related]
14. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
15. A prothrombinase-based assay for detection of resistance to activated protein C.
Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
[TBL] [Abstract][Full Text] [Related]
16. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
[TBL] [Abstract][Full Text] [Related]
17. Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.
Girolami A; Saggin L; Gazzetta R; Saltarin P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):610-6. PubMed ID: 6170557
[TBL] [Abstract][Full Text] [Related]
18. Determination of plasma prothrombin level by Ca2+-dependent prothrombin activator (CA-1) during warfarin anticoagulation.
Iwahashi H; Kimura M; Nakajima K; Yamada D; Morita T
J Heart Valve Dis; 2001 May; 10(3):388-92. PubMed ID: 11380105
[TBL] [Abstract][Full Text] [Related]
19. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
Roberts PS; Hughes HN; Fleming PB
Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
[TBL] [Abstract][Full Text] [Related]
20. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
